YILDIRIM, T. Et Al. 2012. Major Barriers against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?. RENAL FAILURE , vol.34, no.9 , 1095-1099.

YILDIRIM, T., ARICI, M., Piskinpasa, S., Aybal-Kutlugun, A., Yilmaz, R., ALTUN, B., ... ERDEM, Y.(2012). Major Barriers against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?. RENAL FAILURE , vol.34, no.9, 1095-1099.

YILDIRIM, TOLGA Et Al. "Major Barriers against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?," RENAL FAILURE , vol.34, no.9, 1095-1099, 2012

YILDIRIM, TOLGA Et Al. "Major Barriers against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?." RENAL FAILURE , vol.34, no.9, pp.1095-1099, 2012

YILDIRIM, T. Et Al. (2012) . "Major Barriers against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?." RENAL FAILURE , vol.34, no.9, pp.1095-1099.

@article{article, author={TOLGA YILDIRIM Et Al. }, title={Major Barriers against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?}, journal={RENAL FAILURE}, year=2012, pages={1095-1099} }